MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ctim.2020.102452

Медицинская библиотека · Complementary therapies in medicine · 2020

The effect of melatonin on treatment of patients with non-alcoholic fatty liver disease: a randomized double blind clinical trial.

Bahrami Mina, Cheraghpour Makan, Jafarirad Sima, Alavinejad Pejman, Asadi Fariba, Hekmatdoost Azita, Mohammadi Mahsa, Yari Zahra

СтатьяРандомизированное исследованиеПеревод в очереди

Аннотация

OBJECTIVES

Many factors implicated in the pathogenesis of non-alcoholic fatty liver disease (NAFLD) are including oxidative stress, insulin resistance and abnormal production of adipokines. The aim of this clinical trial was to evaluate the effect of melatonin supplement on some important biochemical markers and signs related to NAFLD.

DESIGN

A randomized double-blind, placebo-controlled, clinical trial.

SETTING

Twenty-four participants in the melatonin group and 21 participants in the placebo group completed the study.

INTERVENTION: Participants received 6 mg melatonin or placebo daily, 1 h before bedtime. The intervention period was 12 weeks.

MAIN OUTCOME MEASURES: Anthropometric measurements, systolic and diastolic blood pressure, liver enzymes, high sensitive C‑reactive protein (hs-CRP), fatty liver grade, also leptin and adiponectin serum levels, were measured at the baseline and the end of intervention.

RESULTS

A significant improvement was observed in weight (p = 0.043), waist circumference (p = 0.027), abdominal circumference (p = 0.043), systolic (p = 0.039), and diastolic (p = 0.015) blood pressure, leptin serum levels (p = 0.032), hs-CRP (p = 0.024), alanine aminotransferase (p = 0.011), aspartate aminotransferase (p = 0.034), also the grade of fatty liver (p = 0.020) in melatonin treated group compared with the placebo.

CONCLUSIONS

Administration of 6 mg/day melatonin had improvement effect on many factors related to NAFLD such as liver enzymes, hs-CRP, anthropometric measurements, blood pressure, leptin serum levels and the grade of fatty liver.

Для цитирования: Bahrami Mina, Cheraghpour Makan, Jafarirad Sima, Alavinejad Pejman, Asadi Fariba, Hekmatdoost Azita, Mohammadi Mahsa, Yari Zahra. The effect of melatonin on treatment of patients with non-alcoholic fatty liver disease: a randomized double blind clinical trial.. Complementary therapies in medicine. 2020. DOI: 10.1016/j.ctim.2020.102452.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.